SUPN
Supernus Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Last
$49.46
−$0.44 (−0.87%) 4:00 PM ET
After hours
$49.47
+$0.01 (+0.02%) 4:12 PM ET
Prev close $49.89
Open $50.04
Day high $50.04
Day low $48.38
Volume 345,938
Avg vol 650,120
Mkt cap
$2.85B
P/E ratio
-145.46
FY Revenue
$681.54M
EPS
-0.34
Gross Margin
88.61%
Sector
Healthcare
AI report sections
SUPN
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. shows strong positive price momentum over the past 6–12 months with the stock trading in the upper portion of its 52-week range and above key moving averages. At the same time, recent profitability has turned negative despite high gross margins and positive free cash flow, indicating a divergence between operating performance and cash generation. Short interest metrics and technical breakouts point to elevated positioning risk and potential for volatility even as news flow has been broadly constructive.
AI summarized at 3:16 AM ET, 2025-12-20
AI summary scores
INTRADAY: 63 SWING: 72 LONG: 58
Volume vs average
Intraday (cumulative)
−17% (Below avg)
Vol/Avg: 0.83×
RSI
55.24 (Neutral)
Neutral (30–70): momentum balanced.
MACD momentum
Intraday
-0.02 (Weak)
MACD: -0.01 Signal: 0.01
Short-Term
+0.21 (Strong)
MACD: 1.06 Signal: 0.86
Long-Term
+0.39 (Strong)
MACD: 0.73 Signal: 0.34
Intraday trend score 53.72
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal